News
Nanobody: The Breakthrough on Thrombosis Treatment
Nov 15, 2024Introduction Factor XII (FXII), a key player in blood coagulation and inflammation, has emerged as a promising therapeutic target. Researchers have developed a nanoantibody (Nb) targeting FXII with high affinity and neutralizing activity. Anti-thromb...
Read More-
The Versatile Role of eGFP Reporter RNA
Nov 13, 2024In the intricate world of molecular biology, fluorescent proteins have emerged as invaluable tools, enabling researchers to visualize and track cellular processes in real-time. Among these, Enhanced Green Fluorescent Protein (eGFP) stands out as a be...
Read More -
Gene Therapy Evolution: Novel DNA & Optimization
Nov 12, 2024In the field of DNA applications, plasmid DNA (pDNA) has always been highly favored due to its exceptional stability, ease of production, storage, and transportation. However, as scientific research continues to advance, a series of novel DNA types, ...
Read More -
Championing Reporter RNA Modification Methods
Nov 08, 2024When choosing which method of reporter mRNA modifications is preferable, there is no definitive answer as each method and reporter gene has its own advantages and applicable scenarios. Here are some common mRNA modification methods and reporter genes...
Read More -
Overcoming Challenges in Recombinant Protein Purification
Nov 07, 2024In recent decades, recombinant proteins have proven crucial in combating various diseases, demonstrating great potential. With advancements in genetic engineering, significant breakthroughs have been made in protein drug research. Technologies like f...
Read More -
Investigate the Purity of RNA: Ion Exchange Chromatography
Nov 06, 2024Ion-exchange chromatography effectively purifies RNA by separating molecules with different charges. Depending on their protonation state at various pH levels, RNA molecules can carry positive or negative charges. This property is utilized in ion exc...
Read More -
CVB1-VLP: The Pioneer of Enterovirus VLP Vaccines
Nov 05, 2024Coxsackievirus B1 (CVB1), a member of the enterovirus B species, is a common cause of acute and chronic myocarditis, dilated cardiomyopathy, and purulent meningitis. However, there is currently no vaccine against CVB1. In June 2023, researchers from ...
Read More -
Revolutionizing Discovery in mRNA Targeted Delivery Research
Nov 04, 2024Today Yaohai Bio-Pharma summarized the latest research results of two mRNA giants in targeted delivery, focusing on the perspective of mRNA sequence design and optimization, and combining publicly available patents and literature. The application of ...
Read More -
The Power of Plasmid Purification Technology
Oct 30, 2024Today, Yaohai Bio-Pharma will introduce a method for purifying Plasmid DNA by ion exchange chromatography. Ion exchange chromatography mainly uses solute molecules to combine with solid phase ion exchangers carrying opposite charges. In the case...
Read More -
Revolutionizing DNA Vaccine with Nanocarrier
Oct 29, 2024DNA vaccine technology holds great potential for treating diseases like cancer, atherosclerosis, and diabetes. It involves delivering DNA-encoding protein antigens into cells to produce specific proteins, which are then presented to the immune system...
Read More -
Explore the Fascinating World of the Lithium Chloride Precipitation
Oct 28, 2024Lithium chloride precipitation is widely used for separating RNA from solution. Here's the breakdown of the process: 1. Sample preparation: Start with a sample containing RNA, such as in-vitro transcript mixture. 2. Lithium chloride addition: Add an...
Read More -
Recombinant Protein Production: Engineered E. coli Strains
Oct 25, 2024Escherichia coli (E. coli) has played a significant role in producing recombinant proteins in the biopharmaceutical industry, serving as the first expression vector for manufacturing biological medicine. E. coli boasts rapid growth, convenient geneti...
Read More -
2024 Updated mRNA Purification Methods
Oct 23, 2024Purification, a crucial step in mRNA production, involves removing impurities such as unreacted chemicals or residual materials. The purification process ensures batch-to-batch consistency of mRNA and lipid nanoparticle (LNP) formulations, removing u...
Read More -
The Magic of P. pastoris: Shaping Recombinant Protein Production
Oct 16, 2024Recombinant proteins, which are proteins expressed in host cells through genetic engineering techniques, have found widespread applications in biomedical research, therapy, and diagnostics. The selection of an appropriate expression system is a cruci...
Read More -
DNA Vaccine Production Scale-up Strategies
Oct 14, 2024Since the initial demonstration of gene expression in vivo through naked DNA injection, DNA vaccines, and gene therapies have advanced significantly. Plasmid DNA is used in both approaches to treat diseases by inducing protein expression. In comparis...
Read More -
Nanobodies Meet CAR-T: Shaping the Future of Cancer Therapy
Oct 10, 2024Chimeric Antigen Receptor T-cell (CAR-T) therapy is an emerging cellular immunotherapy that genetically modifies T-cells to express Chimeric Antigen Receptors (CARs) on their surfaces. These receptors enable T-cells to recognize and specifically targ...
Read More -
The Manufacturing Process and Applications of Nanobody
Oct 09, 2024By targeting specific viruses or structures, engineered antibodies can potentially treat certain high-risk populations. However, similar to monoclonal antibodies, their widespread application is hindered by the high production costs and their large s...
Read More -
Plasmid DNA: The Key to Unlocking Cancer's Therapy Code
Sep 27, 2024Recently, gene therapy has showcased the huge potential in cancer treatment. It can introduce exogenous normal genes into human target cells to repair, replace, or modulate genes within the patient, ultimately achieving therapeutic goals at the ...
Read More -
Polypeptides Drugs: The Future of Biomedicine
Sep 26, 2024The market for polypeptide drugs is experiencing rapid growth in the biomedical sector, with an annual compound growth rate of 8.5% globally from 2020 to 2030, expected to reach US$141.8 billion by 2030. Polypeptide drugs are produced via methods lik...
Read More -
Yeast: Key Player in VLP Vaccine for Polio
Sep 25, 2024Poliomyelitis (polio) is caused by a virus, with symptoms including fever, upper respiratory discomfort, and limb paralysis. The disease is preventable but difficult to cure, and can easily lead to lifelong disability or even death. Thus, vaccines ar...
Read More
Hot News
-
Yaohai Bio-Pharma Passed EU QP Audit and Attains ISO Triple Certification
2024-05-08
-
BiotechGate, Online
2024-05-13
-
2024 WORLD VACCINE CONGRESS Washington
2024-04-01
-
CPHI North America 2024
2024-05-07
-
BIO International Convention 2024
2024-06-03
-
FCE COSMETIQUE
2024-06-04
-
CPHI Milan 2024
2024-10-08